Advertisement

Topics

Astellas Pharma Canada, Inc. Company Profile

16:47 EDT 25th September 2017 | BioPortfolio

Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. As a global company, Astellas is committed to combining outstanding research and development (R&D) and marketing capabilities to continue to grow in the world pharmaceutical market. Astellas Pharma Europe Ltd. manages 21 affiliate offices located across Europe, the Middle East and Africa. In addition, the Company has an R&D site and three manufacturing plants in Europe. The company employs approximately 4,300 staff across these regions. For more information about Astellas Pharma Europe, please visit http://www.astellas.eu


News Articles [3047 Associated News Articles listed on BioPortfolio]

Astellas Supports the Northern Kyushu Heavy Rain Relief Efforts

Tokyo, July 13, 2017– Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, “Astellas”) would like to express our deepest sympathy to the victims of the heavy rain hit to No...

ABPI Extends Suspension of Astellas UK

The Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK’s membership for a further 12 months from Jun. 24 because of several serious breaches of its Code of Pract...

LTL Pharma Succeeds Marketing Approval for "Nivadil® Tablets", "Solantal® Tablets" and "Lowgan® Tablets", and isTransferred Distribution Rights in Japan

Tokyo (Japan), August 1, 2017 –LTL Pharma Co., Ltd. (Representative Director, Chairman: Sansei Oka, Representative Director, President: Jiro Mizukawa, “LTL Pharma”) and Astellas Ph...

Promotions at Astellas in the USA

Japanese pharma major Astellas Pharma today announced two senior-level promotions in its Marketing Strategy…

Astellas Pharma Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

Astellas Pharma Inc. Strategy, SWOT and Corporate Finance ReportSummaryAstellas Pharma Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. Th...

Astellas AML Inhibitor Granted Orphan Drug Designation

NewsU.S. FDA grants orphan-drug designation to Astellas for development of FLT3 inhibitor gilteritinib in acute myeloid leukemia.

Supplemental NDA for Astellas' Overactive Bladder Treatment Reviewed by FDA

NewsU.S. FDA accepts for review Astellas' supplemental New Drug Application for mirabegron for use in combination with solifenacin succinate 5 mg for the treatment of overactive bladder.

Astellas Pharma Canada, Inc. Grows Partnership With The Canadian National Transplant Research Program To Catalyze Innovative Research In Transplantation

  Life Sciences Jobs   ...

Drugs and Medications [597 Associated Drugs and Medications listed on BioPortfolio]

Vesicare [Astellas Pharma Technologies, Inc.]

These highlights do not include all the information needed to use VESIcare safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. ...

Vivierskin sunscreen [Vivier Pharma, Inc.]

Vivierskin Sunscreen Lotion SPF 30

Skintx medicated acne wash [Vivier Pharma, Inc.]

SkinTX Medicated Acne Wash Salicylic Acid USP 2%

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

PubMed Articles [458 Associated PubMed Articles listed on BioPortfolio]

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Clinician's Commentary on Figueiredo et al.(1).

Clinician's Commentary on Coghlan et al.(1).

Clinician's Commentary on Yoon et al.(1).

Sex with Neighbors: Canada and Canadians in the "U.S." Homophile Press.

This article examines U.S. homophile magazine contributions from and representations of Canada from 1953 to 1964. Drawing on 240 articles, letters, and other items that were published in ONE, Mattachi...

Clinical Trials [448 Associated Clinical Trials listed on BioPortfolio]

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Magicbuvir 400 m...

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 5 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 1 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

The purpose of the study is to provide access to continued treatment for subjects who participated in other Astellas sponsored ASP2215 trials and for whom the Investigator feels the subjec...

Companies [1443 Associated Companies listed on BioPortfolio]

Astellas Pharma Canada, Inc.

Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...

Astellas Pharma Global Development

Astellas Pharma Global Development, located in Deerfield, Illinois, is a group company of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of peo...

Astellas Pharma Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals...

Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around...

Potenza Therapeutics, Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and rel...

More Information about "Astellas Pharma Canada, Inc." on BioPortfolio

We have published hundreds of Astellas Pharma Canada, Inc. news stories on BioPortfolio along with dozens of Astellas Pharma Canada, Inc. Clinical Trials and PubMed Articles about Astellas Pharma Canada, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Astellas Pharma Canada, Inc. Companies in our database. You can also find out about relevant Astellas Pharma Canada, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record